<--- Back to Details
First PageDocument Content
Cancer treatments / Prodrugs / Organofluorides / FOLFIRI / Irinotecan / Fluorouracil / Adjuvant therapy / Mucositis / FOLFOX / Medicine / Chemotherapy regimens / Pharmacology
Date: 2011-11-02 17:53:47
Cancer treatments
Prodrugs
Organofluorides
FOLFIRI
Irinotecan
Fluorouracil
Adjuvant therapy
Mucositis
FOLFOX
Medicine
Chemotherapy regimens
Pharmacology

DOI: jimabJournal of IMAB - Annual Proceeding (Scientific Papers) 2008, vol. 14, book 1 IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER Deyan Davidov Department

Add to Reading List

Source URL: www.journal-imab-bg.org

Download Document from Source Website

File Size: 127,87 KB

Share Document on Facebook

Similar Documents

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

DocID: 1reFq - View Document

Bevacizumab+ FOLFOX  (f.d.OxModdG) (colorektal) Bevacizumab (Avastin) 5 mg/kg (om lämpligt, jämna 100-tal) iv infmin iv infmin

Bevacizumab+ FOLFOX (f.d.OxModdG) (colorektal) Bevacizumab (Avastin) 5 mg/kg (om lämpligt, jämna 100-tal) iv infmin iv infmin

DocID: 1e3Ep - View Document

Cetuximab/FOLFOX Cetuximab Oxaliplatin Calciumfolinat 5-Fluorouracil 5-Fluorouracil

Cetuximab/FOLFOX Cetuximab Oxaliplatin Calciumfolinat 5-Fluorouracil 5-Fluorouracil

DocID: 1d2uk - View Document

Bristol-Myers Squibb / Cetuximab / Panitumumab / KRAS / Bevacizumab / Immune system / Oxaliplatin / Colorectal cancer / FOLFOX / Medicine / Chemistry / Pharmacology

7.5 PANITUMUMAB, injection, 100 mg/5 mL and 400 mg/20 mL, Vectibix®, Amgen Australia Pty Ltd. Purpose of Application To request that the current Section 100 (Efficient Funding of Chemotherapy Program) Authority Require

DocID: 17GB7 - View Document

PAR Oxaliplatin 5 mg / ml Concentrate for Solution for Infusion  PL; UK/HDC Public Assessment Report Decentralised Procedure

PAR Oxaliplatin 5 mg / ml Concentrate for Solution for Infusion PL; UK/HDC Public Assessment Report Decentralised Procedure

DocID: 16sDl - View Document